Comparison of the therapeutic effects of sildenafil citrate, heparin and neuropeptides in a rat model of acetic acid-induced gastric ulcer

Life Sciences ◽  
2017 ◽  
Vol 186 ◽  
pp. 102-110 ◽  
Author(s):  
Mehmet Kalayci ◽  
Mehmet Ali Kocdor ◽  
Tuncay Kuloglu ◽  
İbrahim Sahin ◽  
Mehmet Sarac ◽  
...  
2010 ◽  
Vol 45 (8) ◽  
pp. 846-858 ◽  
Author(s):  
Shun Kobayashi ◽  
Noriko Nakajima ◽  
Yoko Ito ◽  
Mitsuhiko Moriyama

2009 ◽  
Vol 43 (6) ◽  
pp. 594-603 ◽  
Author(s):  
Ali Solmaz ◽  
Göksel Şener ◽  
Şule Çetinel ◽  
Meral Yüksel ◽  
Cumhur Yeğen ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Hui Yang ◽  
Yi Lu ◽  
Xiao-Feng Zeng ◽  
Ling Li ◽  
Rong-Ping Zhang ◽  
...  

Background. Baicalin (BA) has been shown to have anti-inflammatory and antioxidant activity. Zinc is a nutrient element. Objective. This study is aimed at investigating the antichronic gastric ulcer activity of Zn-Baicalin complex (BA-Zn) and its related mechanisms in an acetic acid-induced gastric ulcer rat model. Results. The severely ulcerated gastric mucosa of model rats had lower GSH-Px (52.21 ± 7.13) and SOD (7.03 ± 0.10) activity, and higher MDA (2.39 ± 0.03) content compared to sham rats. BA-Zn reduced the gastric ulcer index in a dose-dependent manner, significantly increased SOD activity and GSH-Px level, and reduced the MDA content and IL-8 and TNF-α levels in the gastric mucosa. BA-Zn (6.5 and 13 mg/kg) exerted a greater antiulcerogenic effect than both BA and zinc-gluconate, leading to a reduced ulcer index (18.43 ± 1.11, 15.00 ± 1.44), decreased MDA content (1.33 ± 0.07, 0.63 ± 0.01), and increased SOD activity (17.62 ± 0.11, 20.12 ± 0.32) and GSH-Px levels (102.12 ± 9.11, 120.25 ± 9.07). In addition, our results from Western blot suggested that BA-Zn (6.5 and 13 mg/kg) has a greater antiulcerogenic effect than both BA and zinc-gluconate. Conclusion. The BA-Zn complex possesses greater antichronic gastric ulcer properties compared to BA and zinc-gluconate due to its ability of oxidation resistance and anti-inflammatory effects.


2020 ◽  
Vol 43 (2) ◽  
pp. 405-416 ◽  
Author(s):  
Gulcin Ercan ◽  
Rumeysa Ilbar Tartar ◽  
Ali Solmaz ◽  
Osman Bilgin Gulcicek ◽  
Onur Olgac Karagulle ◽  
...  

2008 ◽  
Vol 42 (3) ◽  
pp. 204-214 ◽  
Author(s):  
Tae Young Oh ◽  
Byung Ok Ahn ◽  
Eun Jung Jang ◽  
Joo Sang Park ◽  
Sang Jong Park ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A153-A153
Author(s):  
S MIYAMOTO ◽  
K KATO ◽  
Y ISHII ◽  
S ASAI ◽  
T NAGAISHI ◽  
...  

Processes ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 1294
Author(s):  
Samuel Álvarez-Almazán ◽  
Gabriel Navarrete-Vázquez ◽  
Itzia Irene Padilla-Martínez ◽  
José Correa-Basurto ◽  
Diana Alemán-González-Duhart ◽  
...  

By activating PPAR-γ, thiazolidinediones normalize glucose levels in animal models of type 2 diabetes and in patients with this pathology. The aim of the present study was to analyze 219 new derivatives in silico and select the best for synthesis, to be evaluated for acute oral toxicity in female rats and for control of diabetes-related parameters in a rat model of streptozotocin-induced diabetes. The best compound was chosen based on pharmacokinetic, pharmacodynamic, and toxicological parameters obtained in silico and binding orientation observed by docking simulations on PPAR-γ. Compound 1G was synthesized by a quick and easy Knoevenagel condensation. Acute oral toxicity was found at a dose greater than 2000 mg/Kg. Compound 1G apparently produces therapeutic effects similar to those of pioglitazone, decreasing glycaemia and triglyceride levels in diabetic animals, without liver damage. Moreover, it did not cause a significant weight gain and tended to reduce polydipsia and polyphagia, while diminishing systemic inflammation related to TNF-α and IL-6. It lowered the level of endogenous antioxidant molecules such as reduced glutathione and glutathione reductase. In conclusion, 1G may be a candidate for further testing as an euglycemic agent capable of preventing the complications of diabetes.


Sign in / Sign up

Export Citation Format

Share Document